nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxycodone—CYP3A5—Gefitinib—lung cancer	0.0462	0.072	CbGbCtD
Oxycodone—CYP3A5—Teniposide—lung cancer	0.0448	0.0698	CbGbCtD
Oxycodone—CYP3A7—Paclitaxel—lung cancer	0.0333	0.0519	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.0333	0.0519	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0329	0.0512	CbGbCtD
Oxycodone—CYP3A7—Irinotecan—lung cancer	0.0329	0.0512	CbGbCtD
Oxycodone—CYP2D6—Gefitinib—lung cancer	0.0283	0.0441	CbGbCtD
Oxycodone—CYP3A5—Crizotinib—lung cancer	0.0283	0.0441	CbGbCtD
Oxycodone—CYP3A5—Erlotinib—lung cancer	0.0273	0.0425	CbGbCtD
Oxycodone—CYP3A5—Paclitaxel—lung cancer	0.025	0.0389	CbGbCtD
Oxycodone—CYP3A5—Irinotecan—lung cancer	0.0247	0.0384	CbGbCtD
Oxycodone—CYP3A7—Docetaxel—lung cancer	0.0241	0.0375	CbGbCtD
Oxycodone—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0241	0.0375	CbGbCtD
Oxycodone—CYP2D6—Vinorelbine—lung cancer	0.0218	0.034	CbGbCtD
Oxycodone—CYP3A5—Etoposide—lung cancer	0.0197	0.0308	CbGbCtD
Oxycodone—CYP3A4—Topotecan—lung cancer	0.0197	0.0307	CbGbCtD
Oxycodone—CYP3A5—Docetaxel—lung cancer	0.0181	0.0282	CbGbCtD
Oxycodone—CYP3A4—Gefitinib—lung cancer	0.018	0.0281	CbGbCtD
Oxycodone—CYP3A4—Teniposide—lung cancer	0.0175	0.0272	CbGbCtD
Oxycodone—CYP2D6—Erlotinib—lung cancer	0.0167	0.0261	CbGbCtD
Oxycodone—CYP3A4—Vinorelbine—lung cancer	0.0139	0.0216	CbGbCtD
Oxycodone—CYP2D6—Vinblastine—lung cancer	0.0134	0.0209	CbGbCtD
Oxycodone—CYP3A4—Crizotinib—lung cancer	0.011	0.0172	CbGbCtD
Oxycodone—CYP3A4—Erlotinib—lung cancer	0.0106	0.0166	CbGbCtD
Oxycodone—CYP3A4—Paclitaxel—lung cancer	0.00975	0.0152	CbGbCtD
Oxycodone—CYP3A4—Irinotecan—lung cancer	0.00961	0.015	CbGbCtD
Oxycodone—CYP3A4—Vinblastine—lung cancer	0.00855	0.0133	CbGbCtD
Oxycodone—CYP2D6—Doxorubicin—lung cancer	0.00826	0.0129	CbGbCtD
Oxycodone—CYP3A4—Etoposide—lung cancer	0.0077	0.012	CbGbCtD
Oxycodone—CYP3A4—Docetaxel—lung cancer	0.00705	0.011	CbGbCtD
Oxycodone—CYP3A4—Doxorubicin—lung cancer	0.00525	0.00818	CbGbCtD
Oxycodone—Galantamine—CHRNA5—lung cancer	0.00235	0.349	CrCbGaD
Oxycodone—Galantamine—CHRNB4—lung cancer	0.00158	0.236	CrCbGaD
Oxycodone—Galantamine—CHRNA3—lung cancer	0.0011	0.163	CrCbGaD
Oxycodone—Naltrexone—UGT1A1—lung cancer	0.00107	0.159	CrCbGaD
Oxycodone—Naltrexone—ABCB1—lung cancer	0.00025	0.0372	CrCbGaD
Oxycodone—Naloxone—ALB—lung cancer	0.000191	0.0284	CrCbGaD
Oxycodone—Naloxone—ABCB1—lung cancer	0.000182	0.0271	CrCbGaD
Oxycodone—Gastrointestinal disorder—Paclitaxel—lung cancer	8.59e-05	0.000315	CcSEcCtD
Oxycodone—Fatigue—Paclitaxel—lung cancer	8.58e-05	0.000315	CcSEcCtD
Oxycodone—Haemorrhage—Methotrexate—lung cancer	8.56e-05	0.000314	CcSEcCtD
Oxycodone—Hepatitis—Methotrexate—lung cancer	8.56e-05	0.000314	CcSEcCtD
Oxycodone—Asthenia—Gemcitabine—lung cancer	8.53e-05	0.000313	CcSEcCtD
Oxycodone—Pain—Paclitaxel—lung cancer	8.51e-05	0.000312	CcSEcCtD
Oxycodone—Constipation—Paclitaxel—lung cancer	8.51e-05	0.000312	CcSEcCtD
Oxycodone—Confusional state—Docetaxel—lung cancer	8.5e-05	0.000312	CcSEcCtD
Oxycodone—Pharyngitis—Methotrexate—lung cancer	8.49e-05	0.000312	CcSEcCtD
Oxycodone—Urinary tract disorder—Methotrexate—lung cancer	8.45e-05	0.00031	CcSEcCtD
Oxycodone—Photosensitivity reaction—Doxorubicin—lung cancer	8.45e-05	0.00031	CcSEcCtD
Oxycodone—Anaphylactic shock—Docetaxel—lung cancer	8.43e-05	0.000309	CcSEcCtD
Oxycodone—Oedema—Docetaxel—lung cancer	8.43e-05	0.000309	CcSEcCtD
Oxycodone—Pruritus—Gemcitabine—lung cancer	8.41e-05	0.000309	CcSEcCtD
Oxycodone—Urethral disorder—Methotrexate—lung cancer	8.39e-05	0.000308	CcSEcCtD
Oxycodone—Infection—Docetaxel—lung cancer	8.38e-05	0.000307	CcSEcCtD
Oxycodone—Weight decreased—Doxorubicin—lung cancer	8.37e-05	0.000307	CcSEcCtD
Oxycodone—Feeling abnormal—Etoposide—lung cancer	8.36e-05	0.000307	CcSEcCtD
Oxycodone—Hyperglycaemia—Doxorubicin—lung cancer	8.35e-05	0.000306	CcSEcCtD
Oxycodone—Diarrhoea—Irinotecan—lung cancer	8.35e-05	0.000306	CcSEcCtD
Oxycodone—Pneumonia—Doxorubicin—lung cancer	8.3e-05	0.000305	CcSEcCtD
Oxycodone—Gastrointestinal pain—Etoposide—lung cancer	8.3e-05	0.000305	CcSEcCtD
Oxycodone—Shock—Docetaxel—lung cancer	8.3e-05	0.000304	CcSEcCtD
Oxycodone—Nervous system disorder—Docetaxel—lung cancer	8.27e-05	0.000304	CcSEcCtD
Oxycodone—Infestation NOS—Doxorubicin—lung cancer	8.25e-05	0.000303	CcSEcCtD
Oxycodone—Infestation—Doxorubicin—lung cancer	8.25e-05	0.000303	CcSEcCtD
Oxycodone—Drowsiness—Doxorubicin—lung cancer	8.25e-05	0.000303	CcSEcCtD
Oxycodone—Visual impairment—Methotrexate—lung cancer	8.25e-05	0.000303	CcSEcCtD
Oxycodone—Tachycardia—Docetaxel—lung cancer	8.23e-05	0.000302	CcSEcCtD
Oxycodone—Feeling abnormal—Paclitaxel—lung cancer	8.2e-05	0.000301	CcSEcCtD
Oxycodone—Skin disorder—Docetaxel—lung cancer	8.19e-05	0.000301	CcSEcCtD
Oxycodone—Hypersensitivity—Cisplatin—lung cancer	8.16e-05	0.000299	CcSEcCtD
Oxycodone—Gastrointestinal pain—Paclitaxel—lung cancer	8.14e-05	0.000299	CcSEcCtD
Oxycodone—Diarrhoea—Gemcitabine—lung cancer	8.13e-05	0.000298	CcSEcCtD
Oxycodone—Dizziness—Irinotecan—lung cancer	8.07e-05	0.000296	CcSEcCtD
Oxycodone—Urticaria—Etoposide—lung cancer	8.06e-05	0.000296	CcSEcCtD
Oxycodone—Stomatitis—Doxorubicin—lung cancer	8.04e-05	0.000295	CcSEcCtD
Oxycodone—Anorexia—Docetaxel—lung cancer	8.04e-05	0.000295	CcSEcCtD
Oxycodone—Abdominal pain—Etoposide—lung cancer	8.02e-05	0.000294	CcSEcCtD
Oxycodone—Body temperature increased—Etoposide—lung cancer	8.02e-05	0.000294	CcSEcCtD
Oxycodone—Urinary tract infection—Doxorubicin—lung cancer	8.02e-05	0.000294	CcSEcCtD
Oxycodone—Eye disorder—Methotrexate—lung cancer	8e-05	0.000293	CcSEcCtD
Oxycodone—Tinnitus—Methotrexate—lung cancer	7.98e-05	0.000293	CcSEcCtD
Oxycodone—Asthenia—Cisplatin—lung cancer	7.95e-05	0.000292	CcSEcCtD
Oxycodone—Cardiac disorder—Methotrexate—lung cancer	7.94e-05	0.000291	CcSEcCtD
Oxycodone—Sweating—Doxorubicin—lung cancer	7.91e-05	0.00029	CcSEcCtD
Oxycodone—Urticaria—Paclitaxel—lung cancer	7.9e-05	0.00029	CcSEcCtD
Oxycodone—Hypotension—Docetaxel—lung cancer	7.88e-05	0.000289	CcSEcCtD
Oxycodone—Haematuria—Doxorubicin—lung cancer	7.87e-05	0.000289	CcSEcCtD
Oxycodone—Abdominal pain—Paclitaxel—lung cancer	7.87e-05	0.000289	CcSEcCtD
Oxycodone—Body temperature increased—Paclitaxel—lung cancer	7.87e-05	0.000289	CcSEcCtD
Oxycodone—Hepatobiliary disease—Doxorubicin—lung cancer	7.81e-05	0.000286	CcSEcCtD
Oxycodone—Epistaxis—Doxorubicin—lung cancer	7.78e-05	0.000286	CcSEcCtD
Oxycodone—Angiopathy—Methotrexate—lung cancer	7.76e-05	0.000285	CcSEcCtD
Oxycodone—Vomiting—Irinotecan—lung cancer	7.76e-05	0.000285	CcSEcCtD
Oxycodone—Sinusitis—Doxorubicin—lung cancer	7.74e-05	0.000284	CcSEcCtD
Oxycodone—Immune system disorder—Methotrexate—lung cancer	7.73e-05	0.000284	CcSEcCtD
Oxycodone—Mediastinal disorder—Methotrexate—lung cancer	7.71e-05	0.000283	CcSEcCtD
Oxycodone—Rash—Irinotecan—lung cancer	7.69e-05	0.000282	CcSEcCtD
Oxycodone—Dermatitis—Irinotecan—lung cancer	7.69e-05	0.000282	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Docetaxel—lung cancer	7.68e-05	0.000282	CcSEcCtD
Oxycodone—Chills—Methotrexate—lung cancer	7.68e-05	0.000282	CcSEcCtD
Oxycodone—Headache—Irinotecan—lung cancer	7.64e-05	0.00028	CcSEcCtD
Oxycodone—Insomnia—Docetaxel—lung cancer	7.63e-05	0.00028	CcSEcCtD
Oxycodone—Diarrhoea—Cisplatin—lung cancer	7.58e-05	0.000278	CcSEcCtD
Oxycodone—Paraesthesia—Docetaxel—lung cancer	7.57e-05	0.000278	CcSEcCtD
Oxycodone—Vomiting—Gemcitabine—lung cancer	7.56e-05	0.000277	CcSEcCtD
Oxycodone—Bradycardia—Doxorubicin—lung cancer	7.54e-05	0.000277	CcSEcCtD
Oxycodone—Dyspnoea—Docetaxel—lung cancer	7.52e-05	0.000276	CcSEcCtD
Oxycodone—Somnolence—Docetaxel—lung cancer	7.5e-05	0.000275	CcSEcCtD
Oxycodone—Mental disorder—Methotrexate—lung cancer	7.5e-05	0.000275	CcSEcCtD
Oxycodone—Rash—Gemcitabine—lung cancer	7.49e-05	0.000275	CcSEcCtD
Oxycodone—Dermatitis—Gemcitabine—lung cancer	7.49e-05	0.000275	CcSEcCtD
Oxycodone—Hypersensitivity—Etoposide—lung cancer	7.48e-05	0.000274	CcSEcCtD
Oxycodone—Malnutrition—Methotrexate—lung cancer	7.45e-05	0.000273	CcSEcCtD
Oxycodone—Haemoglobin—Doxorubicin—lung cancer	7.45e-05	0.000273	CcSEcCtD
Oxycodone—Headache—Gemcitabine—lung cancer	7.45e-05	0.000273	CcSEcCtD
Oxycodone—Rhinitis—Doxorubicin—lung cancer	7.43e-05	0.000273	CcSEcCtD
Oxycodone—Dyspepsia—Docetaxel—lung cancer	7.42e-05	0.000272	CcSEcCtD
Oxycodone—Haemorrhage—Doxorubicin—lung cancer	7.41e-05	0.000272	CcSEcCtD
Oxycodone—Hepatitis—Doxorubicin—lung cancer	7.41e-05	0.000272	CcSEcCtD
Oxycodone—Hypoaesthesia—Doxorubicin—lung cancer	7.37e-05	0.000271	CcSEcCtD
Oxycodone—Pharyngitis—Doxorubicin—lung cancer	7.35e-05	0.00027	CcSEcCtD
Oxycodone—Decreased appetite—Docetaxel—lung cancer	7.33e-05	0.000269	CcSEcCtD
Oxycodone—Hypersensitivity—Paclitaxel—lung cancer	7.33e-05	0.000269	CcSEcCtD
Oxycodone—Urinary tract disorder—Doxorubicin—lung cancer	7.32e-05	0.000268	CcSEcCtD
Oxycodone—Oedema peripheral—Doxorubicin—lung cancer	7.3e-05	0.000268	CcSEcCtD
Oxycodone—Dysgeusia—Methotrexate—lung cancer	7.29e-05	0.000268	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Docetaxel—lung cancer	7.28e-05	0.000267	CcSEcCtD
Oxycodone—Asthenia—Etoposide—lung cancer	7.28e-05	0.000267	CcSEcCtD
Oxycodone—Connective tissue disorder—Doxorubicin—lung cancer	7.28e-05	0.000267	CcSEcCtD
Oxycodone—Fatigue—Docetaxel—lung cancer	7.27e-05	0.000267	CcSEcCtD
Oxycodone—Urethral disorder—Doxorubicin—lung cancer	7.26e-05	0.000266	CcSEcCtD
Oxycodone—Nausea—Irinotecan—lung cancer	7.25e-05	0.000266	CcSEcCtD
Oxycodone—Pain—Docetaxel—lung cancer	7.21e-05	0.000265	CcSEcCtD
Oxycodone—Constipation—Docetaxel—lung cancer	7.21e-05	0.000265	CcSEcCtD
Oxycodone—Back pain—Methotrexate—lung cancer	7.2e-05	0.000264	CcSEcCtD
Oxycodone—Pruritus—Etoposide—lung cancer	7.18e-05	0.000263	CcSEcCtD
Oxycodone—Visual impairment—Doxorubicin—lung cancer	7.14e-05	0.000262	CcSEcCtD
Oxycodone—Asthenia—Paclitaxel—lung cancer	7.14e-05	0.000262	CcSEcCtD
Oxycodone—Nausea—Gemcitabine—lung cancer	7.06e-05	0.000259	CcSEcCtD
Oxycodone—Vomiting—Cisplatin—lung cancer	7.04e-05	0.000258	CcSEcCtD
Oxycodone—Pruritus—Paclitaxel—lung cancer	7.04e-05	0.000258	CcSEcCtD
Oxycodone—Rash—Cisplatin—lung cancer	6.98e-05	0.000256	CcSEcCtD
Oxycodone—Dermatitis—Cisplatin—lung cancer	6.98e-05	0.000256	CcSEcCtD
Oxycodone—Feeling abnormal—Docetaxel—lung cancer	6.95e-05	0.000255	CcSEcCtD
Oxycodone—Diarrhoea—Etoposide—lung cancer	6.94e-05	0.000255	CcSEcCtD
Oxycodone—Eye disorder—Doxorubicin—lung cancer	6.92e-05	0.000254	CcSEcCtD
Oxycodone—Ill-defined disorder—Methotrexate—lung cancer	6.91e-05	0.000254	CcSEcCtD
Oxycodone—Tinnitus—Doxorubicin—lung cancer	6.91e-05	0.000253	CcSEcCtD
Oxycodone—Gastrointestinal pain—Docetaxel—lung cancer	6.9e-05	0.000253	CcSEcCtD
Oxycodone—Anaemia—Methotrexate—lung cancer	6.88e-05	0.000253	CcSEcCtD
Oxycodone—Flushing—Doxorubicin—lung cancer	6.88e-05	0.000252	CcSEcCtD
Oxycodone—Cardiac disorder—Doxorubicin—lung cancer	6.88e-05	0.000252	CcSEcCtD
Oxycodone—Diarrhoea—Paclitaxel—lung cancer	6.81e-05	0.00025	CcSEcCtD
Oxycodone—Angiopathy—Doxorubicin—lung cancer	6.72e-05	0.000247	CcSEcCtD
Oxycodone—Malaise—Methotrexate—lung cancer	6.72e-05	0.000246	CcSEcCtD
Oxycodone—Dizziness—Etoposide—lung cancer	6.71e-05	0.000246	CcSEcCtD
Oxycodone—Immune system disorder—Doxorubicin—lung cancer	6.69e-05	0.000246	CcSEcCtD
Oxycodone—Vertigo—Methotrexate—lung cancer	6.69e-05	0.000246	CcSEcCtD
Oxycodone—Mediastinal disorder—Doxorubicin—lung cancer	6.68e-05	0.000245	CcSEcCtD
Oxycodone—Abdominal pain—Docetaxel—lung cancer	6.67e-05	0.000245	CcSEcCtD
Oxycodone—Body temperature increased—Docetaxel—lung cancer	6.67e-05	0.000245	CcSEcCtD
Oxycodone—Leukopenia—Methotrexate—lung cancer	6.67e-05	0.000245	CcSEcCtD
Oxycodone—Chills—Doxorubicin—lung cancer	6.65e-05	0.000244	CcSEcCtD
Oxycodone—Dizziness—Paclitaxel—lung cancer	6.58e-05	0.000241	CcSEcCtD
Oxycodone—Nausea—Cisplatin—lung cancer	6.58e-05	0.000241	CcSEcCtD
Oxycodone—Cough—Methotrexate—lung cancer	6.5e-05	0.000238	CcSEcCtD
Oxycodone—Mental disorder—Doxorubicin—lung cancer	6.49e-05	0.000238	CcSEcCtD
Oxycodone—Convulsion—Methotrexate—lung cancer	6.45e-05	0.000237	CcSEcCtD
Oxycodone—Vomiting—Etoposide—lung cancer	6.45e-05	0.000237	CcSEcCtD
Oxycodone—Malnutrition—Doxorubicin—lung cancer	6.45e-05	0.000237	CcSEcCtD
Oxycodone—Rash—Etoposide—lung cancer	6.4e-05	0.000235	CcSEcCtD
Oxycodone—Dermatitis—Etoposide—lung cancer	6.39e-05	0.000235	CcSEcCtD
Oxycodone—Headache—Etoposide—lung cancer	6.36e-05	0.000233	CcSEcCtD
Oxycodone—Flatulence—Doxorubicin—lung cancer	6.36e-05	0.000233	CcSEcCtD
Oxycodone—Chest pain—Methotrexate—lung cancer	6.34e-05	0.000233	CcSEcCtD
Oxycodone—Arthralgia—Methotrexate—lung cancer	6.34e-05	0.000233	CcSEcCtD
Oxycodone—Myalgia—Methotrexate—lung cancer	6.34e-05	0.000233	CcSEcCtD
Oxycodone—Tension—Doxorubicin—lung cancer	6.33e-05	0.000232	CcSEcCtD
Oxycodone—Vomiting—Paclitaxel—lung cancer	6.33e-05	0.000232	CcSEcCtD
Oxycodone—Dysgeusia—Doxorubicin—lung cancer	6.32e-05	0.000232	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.3e-05	0.000231	CcSEcCtD
Oxycodone—Rash—Paclitaxel—lung cancer	6.27e-05	0.00023	CcSEcCtD
Oxycodone—Dermatitis—Paclitaxel—lung cancer	6.27e-05	0.00023	CcSEcCtD
Oxycodone—Discomfort—Methotrexate—lung cancer	6.27e-05	0.00023	CcSEcCtD
Oxycodone—Nervousness—Doxorubicin—lung cancer	6.26e-05	0.00023	CcSEcCtD
Oxycodone—Back pain—Doxorubicin—lung cancer	6.24e-05	0.000229	CcSEcCtD
Oxycodone—Headache—Paclitaxel—lung cancer	6.23e-05	0.000229	CcSEcCtD
Oxycodone—Hypersensitivity—Docetaxel—lung cancer	6.21e-05	0.000228	CcSEcCtD
Oxycodone—Muscle spasms—Doxorubicin—lung cancer	6.2e-05	0.000228	CcSEcCtD
Oxycodone—Confusional state—Methotrexate—lung cancer	6.13e-05	0.000225	CcSEcCtD
Oxycodone—Anaphylactic shock—Methotrexate—lung cancer	6.08e-05	0.000223	CcSEcCtD
Oxycodone—Asthenia—Docetaxel—lung cancer	6.05e-05	0.000222	CcSEcCtD
Oxycodone—Infection—Methotrexate—lung cancer	6.04e-05	0.000222	CcSEcCtD
Oxycodone—Nausea—Etoposide—lung cancer	6.03e-05	0.000221	CcSEcCtD
Oxycodone—Ill-defined disorder—Doxorubicin—lung cancer	5.98e-05	0.00022	CcSEcCtD
Oxycodone—Pruritus—Docetaxel—lung cancer	5.97e-05	0.000219	CcSEcCtD
Oxycodone—Nervous system disorder—Methotrexate—lung cancer	5.96e-05	0.000219	CcSEcCtD
Oxycodone—Anaemia—Doxorubicin—lung cancer	5.96e-05	0.000219	CcSEcCtD
Oxycodone—Agitation—Doxorubicin—lung cancer	5.93e-05	0.000217	CcSEcCtD
Oxycodone—Nausea—Paclitaxel—lung cancer	5.91e-05	0.000217	CcSEcCtD
Oxycodone—Skin disorder—Methotrexate—lung cancer	5.9e-05	0.000217	CcSEcCtD
Oxycodone—Hyperhidrosis—Methotrexate—lung cancer	5.88e-05	0.000216	CcSEcCtD
Oxycodone—Malaise—Doxorubicin—lung cancer	5.82e-05	0.000213	CcSEcCtD
Oxycodone—Vertigo—Doxorubicin—lung cancer	5.79e-05	0.000213	CcSEcCtD
Oxycodone—Anorexia—Methotrexate—lung cancer	5.79e-05	0.000213	CcSEcCtD
Oxycodone—Syncope—Doxorubicin—lung cancer	5.78e-05	0.000212	CcSEcCtD
Oxycodone—Leukopenia—Doxorubicin—lung cancer	5.77e-05	0.000212	CcSEcCtD
Oxycodone—Diarrhoea—Docetaxel—lung cancer	5.77e-05	0.000212	CcSEcCtD
Oxycodone—Palpitations—Doxorubicin—lung cancer	5.7e-05	0.000209	CcSEcCtD
Oxycodone—Hypotension—Methotrexate—lung cancer	5.68e-05	0.000208	CcSEcCtD
Oxycodone—Loss of consciousness—Doxorubicin—lung cancer	5.67e-05	0.000208	CcSEcCtD
Oxycodone—Cough—Doxorubicin—lung cancer	5.63e-05	0.000207	CcSEcCtD
Oxycodone—Convulsion—Doxorubicin—lung cancer	5.59e-05	0.000205	CcSEcCtD
Oxycodone—Dizziness—Docetaxel—lung cancer	5.58e-05	0.000205	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Methotrexate—lung cancer	5.54e-05	0.000203	CcSEcCtD
Oxycodone—Insomnia—Methotrexate—lung cancer	5.5e-05	0.000202	CcSEcCtD
Oxycodone—Chest pain—Doxorubicin—lung cancer	5.49e-05	0.000201	CcSEcCtD
Oxycodone—Arthralgia—Doxorubicin—lung cancer	5.49e-05	0.000201	CcSEcCtD
Oxycodone—Myalgia—Doxorubicin—lung cancer	5.49e-05	0.000201	CcSEcCtD
Oxycodone—Anxiety—Doxorubicin—lung cancer	5.47e-05	0.000201	CcSEcCtD
Oxycodone—Paraesthesia—Methotrexate—lung cancer	5.46e-05	0.0002	CcSEcCtD
Oxycodone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	5.45e-05	0.0002	CcSEcCtD
Oxycodone—Discomfort—Doxorubicin—lung cancer	5.43e-05	0.000199	CcSEcCtD
Oxycodone—Dyspnoea—Methotrexate—lung cancer	5.42e-05	0.000199	CcSEcCtD
Oxycodone—Somnolence—Methotrexate—lung cancer	5.4e-05	0.000198	CcSEcCtD
Oxycodone—Dry mouth—Doxorubicin—lung cancer	5.37e-05	0.000197	CcSEcCtD
Oxycodone—Vomiting—Docetaxel—lung cancer	5.36e-05	0.000197	CcSEcCtD
Oxycodone—Dyspepsia—Methotrexate—lung cancer	5.35e-05	0.000196	CcSEcCtD
Oxycodone—Rash—Docetaxel—lung cancer	5.32e-05	0.000195	CcSEcCtD
Oxycodone—Dermatitis—Docetaxel—lung cancer	5.31e-05	0.000195	CcSEcCtD
Oxycodone—Confusional state—Doxorubicin—lung cancer	5.31e-05	0.000195	CcSEcCtD
Oxycodone—Decreased appetite—Methotrexate—lung cancer	5.28e-05	0.000194	CcSEcCtD
Oxycodone—Headache—Docetaxel—lung cancer	5.28e-05	0.000194	CcSEcCtD
Oxycodone—Oedema—Doxorubicin—lung cancer	5.26e-05	0.000193	CcSEcCtD
Oxycodone—Anaphylactic shock—Doxorubicin—lung cancer	5.26e-05	0.000193	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Methotrexate—lung cancer	5.25e-05	0.000193	CcSEcCtD
Oxycodone—Fatigue—Methotrexate—lung cancer	5.24e-05	0.000192	CcSEcCtD
Oxycodone—Infection—Doxorubicin—lung cancer	5.23e-05	0.000192	CcSEcCtD
Oxycodone—Pain—Methotrexate—lung cancer	5.2e-05	0.000191	CcSEcCtD
Oxycodone—Shock—Doxorubicin—lung cancer	5.18e-05	0.00019	CcSEcCtD
Oxycodone—Nervous system disorder—Doxorubicin—lung cancer	5.16e-05	0.000189	CcSEcCtD
Oxycodone—Tachycardia—Doxorubicin—lung cancer	5.14e-05	0.000189	CcSEcCtD
Oxycodone—Skin disorder—Doxorubicin—lung cancer	5.11e-05	0.000188	CcSEcCtD
Oxycodone—Hyperhidrosis—Doxorubicin—lung cancer	5.09e-05	0.000187	CcSEcCtD
Oxycodone—Anorexia—Doxorubicin—lung cancer	5.02e-05	0.000184	CcSEcCtD
Oxycodone—Nausea—Docetaxel—lung cancer	5.01e-05	0.000184	CcSEcCtD
Oxycodone—Feeling abnormal—Methotrexate—lung cancer	5.01e-05	0.000184	CcSEcCtD
Oxycodone—Gastrointestinal pain—Methotrexate—lung cancer	4.97e-05	0.000182	CcSEcCtD
Oxycodone—Hypotension—Doxorubicin—lung cancer	4.92e-05	0.00018	CcSEcCtD
Oxycodone—Urticaria—Methotrexate—lung cancer	4.83e-05	0.000177	CcSEcCtD
Oxycodone—Body temperature increased—Methotrexate—lung cancer	4.81e-05	0.000176	CcSEcCtD
Oxycodone—Abdominal pain—Methotrexate—lung cancer	4.81e-05	0.000176	CcSEcCtD
Oxycodone—Musculoskeletal discomfort—Doxorubicin—lung cancer	4.8e-05	0.000176	CcSEcCtD
Oxycodone—Insomnia—Doxorubicin—lung cancer	4.76e-05	0.000175	CcSEcCtD
Oxycodone—Paraesthesia—Doxorubicin—lung cancer	4.73e-05	0.000173	CcSEcCtD
Oxycodone—Dyspnoea—Doxorubicin—lung cancer	4.69e-05	0.000172	CcSEcCtD
Oxycodone—Somnolence—Doxorubicin—lung cancer	4.68e-05	0.000172	CcSEcCtD
Oxycodone—Dyspepsia—Doxorubicin—lung cancer	4.63e-05	0.00017	CcSEcCtD
Oxycodone—Decreased appetite—Doxorubicin—lung cancer	4.58e-05	0.000168	CcSEcCtD
Oxycodone—Gastrointestinal disorder—Doxorubicin—lung cancer	4.54e-05	0.000167	CcSEcCtD
Oxycodone—Fatigue—Doxorubicin—lung cancer	4.54e-05	0.000167	CcSEcCtD
Oxycodone—Pain—Doxorubicin—lung cancer	4.5e-05	0.000165	CcSEcCtD
Oxycodone—Constipation—Doxorubicin—lung cancer	4.5e-05	0.000165	CcSEcCtD
Oxycodone—Hypersensitivity—Methotrexate—lung cancer	4.48e-05	0.000164	CcSEcCtD
Oxycodone—Asthenia—Methotrexate—lung cancer	4.36e-05	0.00016	CcSEcCtD
Oxycodone—Feeling abnormal—Doxorubicin—lung cancer	4.34e-05	0.000159	CcSEcCtD
Oxycodone—Gastrointestinal pain—Doxorubicin—lung cancer	4.3e-05	0.000158	CcSEcCtD
Oxycodone—Pruritus—Methotrexate—lung cancer	4.3e-05	0.000158	CcSEcCtD
Oxycodone—Urticaria—Doxorubicin—lung cancer	4.18e-05	0.000153	CcSEcCtD
Oxycodone—Body temperature increased—Doxorubicin—lung cancer	4.16e-05	0.000153	CcSEcCtD
Oxycodone—Abdominal pain—Doxorubicin—lung cancer	4.16e-05	0.000153	CcSEcCtD
Oxycodone—Diarrhoea—Methotrexate—lung cancer	4.16e-05	0.000153	CcSEcCtD
Oxycodone—Dizziness—Methotrexate—lung cancer	4.02e-05	0.000148	CcSEcCtD
Oxycodone—Hypersensitivity—Doxorubicin—lung cancer	3.88e-05	0.000142	CcSEcCtD
Oxycodone—Vomiting—Methotrexate—lung cancer	3.87e-05	0.000142	CcSEcCtD
Oxycodone—Rash—Methotrexate—lung cancer	3.83e-05	0.000141	CcSEcCtD
Oxycodone—Dermatitis—Methotrexate—lung cancer	3.83e-05	0.000141	CcSEcCtD
Oxycodone—Headache—Methotrexate—lung cancer	3.81e-05	0.00014	CcSEcCtD
Oxycodone—Asthenia—Doxorubicin—lung cancer	3.78e-05	0.000139	CcSEcCtD
Oxycodone—Pruritus—Doxorubicin—lung cancer	3.72e-05	0.000137	CcSEcCtD
Oxycodone—Nausea—Methotrexate—lung cancer	3.61e-05	0.000132	CcSEcCtD
Oxycodone—Diarrhoea—Doxorubicin—lung cancer	3.6e-05	0.000132	CcSEcCtD
Oxycodone—Dizziness—Doxorubicin—lung cancer	3.48e-05	0.000128	CcSEcCtD
Oxycodone—Vomiting—Doxorubicin—lung cancer	3.35e-05	0.000123	CcSEcCtD
Oxycodone—Rash—Doxorubicin—lung cancer	3.32e-05	0.000122	CcSEcCtD
Oxycodone—Dermatitis—Doxorubicin—lung cancer	3.32e-05	0.000122	CcSEcCtD
Oxycodone—Headache—Doxorubicin—lung cancer	3.3e-05	0.000121	CcSEcCtD
Oxycodone—Nausea—Doxorubicin—lung cancer	3.13e-05	0.000115	CcSEcCtD
Oxycodone—OPRD1—Signaling Pathways—CREBBP—lung cancer	1.3e-05	0.000164	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—CXCL8—lung cancer	1.29e-05	0.000164	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALDOA—lung cancer	1.29e-05	0.000163	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2A7—lung cancer	1.29e-05	0.000163	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ERBB3—lung cancer	1.29e-05	0.000163	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—EGFR—lung cancer	1.28e-05	0.000161	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—SDC4—lung cancer	1.26e-05	0.00016	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NCOA3—lung cancer	1.25e-05	0.000159	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAP2K1—lung cancer	1.24e-05	0.000157	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL2—lung cancer	1.24e-05	0.000156	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TERT—lung cancer	1.23e-05	0.000156	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CD—lung cancer	1.23e-05	0.000156	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CG—lung cancer	1.23e-05	0.000155	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—APC—lung cancer	1.23e-05	0.000155	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KIT—lung cancer	1.23e-05	0.000155	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—NRAS—lung cancer	1.23e-05	0.000155	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—STK11—lung cancer	1.22e-05	0.000155	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ABCG2—lung cancer	1.22e-05	0.000154	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ADCY1—lung cancer	1.22e-05	0.000154	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—PIK3CA—lung cancer	1.22e-05	0.000154	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGF—lung cancer	1.21e-05	0.000154	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—KRAS—lung cancer	1.21e-05	0.000153	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ENO2—lung cancer	1.2e-05	0.000151	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—HPGDS—lung cancer	1.2e-05	0.000151	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—FGFR1—lung cancer	1.2e-05	0.000151	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.19e-05	0.00015	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HIF1A—lung cancer	1.18e-05	0.000149	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—MAPK3—lung cancer	1.18e-05	0.000149	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—APOA1—lung cancer	1.17e-05	0.000148	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—POMC—lung cancer	1.17e-05	0.000148	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTT1—lung cancer	1.16e-05	0.000147	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—BRAF—lung cancer	1.15e-05	0.000146	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—RRM1—lung cancer	1.15e-05	0.000146	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTA3—lung cancer	1.15e-05	0.000146	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP2A6—lung cancer	1.15e-05	0.000145	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GCLC—lung cancer	1.15e-05	0.000145	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6R—lung cancer	1.14e-05	0.000144	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CREBBP—lung cancer	1.14e-05	0.000144	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APOA1—lung cancer	1.14e-05	0.000144	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTP1—lung cancer	1.13e-05	0.000143	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KDR—lung cancer	1.13e-05	0.000143	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—EGFR—lung cancer	1.12e-05	0.000142	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—PIK3CA—lung cancer	1.11e-05	0.00014	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MDM2—lung cancer	1.1e-05	0.00014	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CAT—lung cancer	1.1e-05	0.000139	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—RAF1—lung cancer	1.1e-05	0.000139	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—ERBB2—lung cancer	1.09e-05	0.000138	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ENO1—lung cancer	1.09e-05	0.000138	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAP2K1—lung cancer	1.09e-05	0.000138	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—B4GALT5—lung cancer	1.08e-05	0.000137	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CD—lung cancer	1.08e-05	0.000137	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CB—lung cancer	1.07e-05	0.000136	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MTOR—lung cancer	1.07e-05	0.000136	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ABCB1—lung cancer	1.07e-05	0.000135	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—PIK3CA—lung cancer	1.07e-05	0.000135	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CG—lung cancer	1.07e-05	0.000135	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—KRAS—lung cancer	1.06e-05	0.000134	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTA4—lung cancer	1.05e-05	0.000133	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—TYMS—lung cancer	1.05e-05	0.000133	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—GSTM1—lung cancer	1.04e-05	0.000132	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KIT—lung cancer	1.04e-05	0.000131	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CG—lung cancer	1.04e-05	0.000131	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—APC—lung cancer	1.04e-05	0.000131	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—NRAS—lung cancer	1.04e-05	0.000131	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CXCL8—lung cancer	1.03e-05	0.00013	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGF—lung cancer	1.03e-05	0.00013	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTA2—lung cancer	1.03e-05	0.00013	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—HRAS—lung cancer	1.02e-05	0.00013	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—POMC—lung cancer	1.02e-05	0.000129	CbGpPWpGaD
Oxycodone—OPRD1—GPCR downstream signaling—AKT1—lung cancer	9.96e-06	0.000126	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—MAPK3—lung cancer	9.94e-06	0.000126	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—CREBBP—lung cancer	9.9e-06	0.000125	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTA1—lung cancer	9.89e-06	0.000125	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—POMC—lung cancer	9.88e-06	0.000125	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CASP3—lung cancer	9.87e-06	0.000125	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL2—lung cancer	9.85e-06	0.000125	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CYP1A1—lung cancer	9.85e-06	0.000125	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—IL6—lung cancer	9.81e-06	0.000124	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCC3—lung cancer	9.78e-06	0.000124	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ERCC2—lung cancer	9.77e-06	0.000124	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—BRAF—lung cancer	9.75e-06	0.000123	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP2E1—lung cancer	9.75e-06	0.000123	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—PIK3CA—lung cancer	9.71e-06	0.000123	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MDM2—lung cancer	9.67e-06	0.000122	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—NQO1—lung cancer	9.64e-06	0.000122	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—RAF1—lung cancer	9.64e-06	0.000122	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6R—lung cancer	9.64e-06	0.000122	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CREBBP—lung cancer	9.62e-06	0.000122	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CCND1—lung cancer	9.61e-06	0.000122	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—JUN—lung cancer	9.59e-06	0.000121	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—ERBB2—lung cancer	9.53e-06	0.000121	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKR1C1—lung cancer	9.47e-06	0.00012	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—EGFR—lung cancer	9.45e-06	0.00012	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CB—lung cancer	9.41e-06	0.000119	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MTOR—lung cancer	9.41e-06	0.000119	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CD—lung cancer	9.38e-06	0.000119	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MMP9—lung cancer	9.33e-06	0.000118	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—CDKN1A—lung cancer	9.29e-06	0.000118	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PTEN—lung cancer	9.27e-06	0.000117	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—ALB—lung cancer	9.26e-06	0.000117	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—UGT1A1—lung cancer	9.2e-06	0.000116	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAP2K1—lung cancer	9.18e-06	0.000116	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CD—lung cancer	9.12e-06	0.000115	CbGpPWpGaD
Oxycodone—OPRD1—Signaling by GPCR—AKT1—lung cancer	9.05e-06	0.000114	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CXCL8—lung cancer	9.04e-06	0.000114	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—PIK3CA—lung cancer	9.04e-06	0.000114	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—HRAS—lung cancer	8.98e-06	0.000114	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—KRAS—lung cancer	8.93e-06	0.000113	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GNG11—lung cancer	8.87e-06	0.000112	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EP300—lung cancer	8.84e-06	0.000112	CbGpPWpGaD
Oxycodone—OPRK1—GPCR downstream signaling—AKT1—lung cancer	8.73e-06	0.000111	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—STK11—lung cancer	8.69e-06	0.00011	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CASP3—lung cancer	8.65e-06	0.00011	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL2—lung cancer	8.64e-06	0.000109	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—SRC—lung cancer	8.6e-06	0.000109	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—IL6—lung cancer	8.6e-06	0.000109	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—APOA1—lung cancer	8.45e-06	0.000107	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALDOA—lung cancer	8.44e-06	0.000107	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CCND1—lung cancer	8.42e-06	0.000107	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—JUN—lung cancer	8.41e-06	0.000106	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—VEGFA—lung cancer	8.37e-06	0.000106	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—STAT3—lung cancer	8.29e-06	0.000105	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—NRAS—lung cancer	8.27e-06	0.000105	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—PIK3CA—lung cancer	8.21e-06	0.000104	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NCOA3—lung cancer	8.2e-06	0.000104	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CB—lung cancer	8.18e-06	0.000104	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MMP9—lung cancer	8.18e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MDM2—lung cancer	8.17e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—CDKN1A—lung cancer	8.15e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—RAF1—lung cancer	8.14e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PTEN—lung cancer	8.13e-06	0.000103	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTGS2—lung cancer	8.1e-06	0.000103	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—ERBB2—lung cancer	8.06e-06	0.000102	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTP1—lung cancer	8.04e-06	0.000102	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCG2—lung cancer	7.97e-06	0.000101	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ADCY1—lung cancer	7.97e-06	0.000101	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CB—lung cancer	7.95e-06	0.000101	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MTOR—lung cancer	7.95e-06	0.000101	CbGpPWpGaD
Oxycodone—OPRK1—Signaling by GPCR—AKT1—lung cancer	7.93e-06	0.0001	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MAPK3—lung cancer	7.92e-06	0.0001	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CAT—lung cancer	7.82e-06	9.9e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—HPGDS—lung cancer	7.82e-06	9.9e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ENO2—lung cancer	7.82e-06	9.9e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.77e-06	9.83e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EP300—lung cancer	7.75e-06	9.81e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CG—lung cancer	7.72e-06	9.76e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—MYC—lung cancer	7.71e-06	9.75e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CXCL8—lung cancer	7.64e-06	9.67e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ABCB1—lung cancer	7.61e-06	9.63e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—HRAS—lung cancer	7.59e-06	9.61e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTT1—lung cancer	7.58e-06	9.6e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—SRC—lung cancer	7.54e-06	9.54e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—EGFR—lung cancer	7.54e-06	9.54e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2A6—lung cancer	7.5e-06	9.49e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GCLC—lung cancer	7.5e-06	9.49e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—TYMS—lung cancer	7.48e-06	9.46e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—GSTM1—lung cancer	7.39e-06	9.35e-05	CbGpPWpGaD
Oxycodone—OPRM1—GPCR downstream signaling—AKT1—lung cancer	7.38e-06	9.34e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—POMC—lung cancer	7.34e-06	9.29e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—VEGFA—lung cancer	7.34e-06	9.29e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CASP3—lung cancer	7.31e-06	9.26e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL2—lung cancer	7.3e-06	9.24e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—STAT3—lung cancer	7.27e-06	9.2e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—IL6—lung cancer	7.27e-06	9.2e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—NRAS—lung cancer	7.25e-06	9.18e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—CREBBP—lung cancer	7.15e-06	9.05e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—KRAS—lung cancer	7.12e-06	9.01e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CCND1—lung cancer	7.12e-06	9.01e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ENO1—lung cancer	7.11e-06	8.99e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—JUN—lung cancer	7.1e-06	8.99e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PTEN—lung cancer	7.07e-06	8.94e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CYP1A1—lung cancer	7e-06	8.86e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ERCC2—lung cancer	6.95e-06	8.79e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MAPK3—lung cancer	6.95e-06	8.79e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MMP9—lung cancer	6.91e-06	8.75e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—CDKN1A—lung cancer	6.89e-06	8.72e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PTEN—lung cancer	6.87e-06	8.7e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CD—lung cancer	6.78e-06	8.58e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—MYC—lung cancer	6.76e-06	8.55e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—EP300—lung cancer	6.74e-06	8.53e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling by GPCR—AKT1—lung cancer	6.7e-06	8.48e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—ALB—lung cancer	6.7e-06	8.47e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—EGFR—lung cancer	6.61e-06	8.36e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EP300—lung cancer	6.55e-06	8.29e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—PIK3CA—lung cancer	6.54e-06	8.28e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP2E1—lung cancer	6.37e-06	8.07e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—SRC—lung cancer	6.37e-06	8.06e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—TP53—lung cancer	6.33e-06	8.01e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—NQO1—lung cancer	6.3e-06	7.98e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—KRAS—lung cancer	6.24e-06	7.9e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—VEGFA—lung cancer	6.21e-06	7.85e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—STAT3—lung cancer	6.15e-06	7.78e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—NRAS—lung cancer	6.13e-06	7.76e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—HRAS—lung cancer	6.05e-06	7.66e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—APOA1—lung cancer	6.01e-06	7.61e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CB—lung cancer	5.91e-06	7.48e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MAPK3—lung cancer	5.87e-06	7.43e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTGS2—lung cancer	5.86e-06	7.41e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—IL6—lung cancer	5.79e-06	7.33e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—PIK3CA—lung cancer	5.74e-06	7.26e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—MYC—lung cancer	5.71e-06	7.23e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—STK11—lung cancer	5.68e-06	7.19e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—EGFR—lung cancer	5.59e-06	7.07e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—TP53—lung cancer	5.55e-06	7.02e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CG—lung cancer	5.49e-06	6.94e-05	CbGpPWpGaD
Oxycodone—OPRD1—Signaling Pathways—AKT1—lung cancer	5.34e-06	6.76e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—HRAS—lung cancer	5.31e-06	6.72e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—KRAS—lung cancer	5.28e-06	6.68e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTP1—lung cancer	5.26e-06	6.65e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—POMC—lung cancer	5.22e-06	6.61e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CAT—lung cancer	5.12e-06	6.47e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PTEN—lung cancer	5.11e-06	6.47e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—CREBBP—lung cancer	5.09e-06	6.44e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—IL6—lung cancer	5.08e-06	6.43e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—PIK3CA—lung cancer	4.99e-06	6.31e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ABCB1—lung cancer	4.98e-06	6.3e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—TYMS—lung cancer	4.89e-06	6.19e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—EP300—lung cancer	4.87e-06	6.17e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—PIK3CA—lung cancer	4.85e-06	6.13e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—GSTM1—lung cancer	4.83e-06	6.11e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CD—lung cancer	4.82e-06	6.1e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—ALB—lung cancer	4.76e-06	6.03e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—TP53—lung cancer	4.69e-06	5.93e-05	CbGpPWpGaD
Oxycodone—OPRK1—Signaling Pathways—AKT1—lung cancer	4.69e-06	5.93e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CYP1A1—lung cancer	4.58e-06	5.8e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ERCC2—lung cancer	4.54e-06	5.75e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—HRAS—lung cancer	4.48e-06	5.68e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—IL6—lung cancer	4.29e-06	5.43e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CB—lung cancer	4.2e-06	5.32e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTGS2—lung cancer	4.17e-06	5.27e-05	CbGpPWpGaD
Oxycodone—CYP3A7—Metabolism—AKT1—lung cancer	4.07e-06	5.15e-05	CbGpPWpGaD
Oxycodone—OPRM1—Signaling Pathways—AKT1—lung cancer	3.96e-06	5.01e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—APOA1—lung cancer	3.93e-06	4.97e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PTEN—lung cancer	3.63e-06	4.6e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—PIK3CA—lung cancer	3.6e-06	4.56e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CG—lung cancer	3.59e-06	4.54e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—EP300—lung cancer	3.46e-06	4.38e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—POMC—lung cancer	3.41e-06	4.32e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—CREBBP—lung cancer	3.33e-06	4.21e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CD—lung cancer	3.15e-06	3.99e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—ALB—lung cancer	3.11e-06	3.94e-05	CbGpPWpGaD
Oxycodone—CYP3A5—Metabolism—AKT1—lung cancer	2.94e-06	3.73e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CB—lung cancer	2.75e-06	3.48e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTGS2—lung cancer	2.72e-06	3.45e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—PIK3CA—lung cancer	2.56e-06	3.24e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PTEN—lung cancer	2.38e-06	3.01e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—EP300—lung cancer	2.27e-06	2.87e-05	CbGpPWpGaD
Oxycodone—CYP2D6—Metabolism—AKT1—lung cancer	2.09e-06	2.65e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—PIK3CA—lung cancer	1.68e-06	2.12e-05	CbGpPWpGaD
Oxycodone—CYP3A4—Metabolism—AKT1—lung cancer	1.37e-06	1.73e-05	CbGpPWpGaD
